These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 11001747)

  • 1. Neurobiology of behavioral changes after prenatal exposure to paroxetine (Paxil).
    Friedman EH
    Am J Obstet Gynecol; 2000 Aug; 183(2):518-9. PubMed ID: 11001747
    [No Abstract]   [Full Text] [Related]  

  • 2. Behavioral changes in developing mice after prenatal exposure to paroxetine (Paxil).
    Coleman FH; Christensen HD; Gonzalez CL; Rayburn WF
    Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 1):1166-71. PubMed ID: 10561639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of acute and chronic antidepressant treatments on memory performance: a comparison between paroxetine and imipramine.
    Naudon L; Hotte M; Jay TM
    Psychopharmacology (Berl); 2007 Apr; 191(2):353-64. PubMed ID: 17219219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant-like effects of paroxetine are produced by lower doses than those which produce nausea.
    Tuerke KJ; Leri F; Parker LA
    Pharmacol Biochem Behav; 2009 Aug; 93(2):190-5. PubMed ID: 19477193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics of clinical effects of paxil in the treatment of endogenous depression].
    Panteleeva GP; Korenev AN; Khananashvili MM; Oleĭchik IV; Kaleda VG
    Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(6):26-31. PubMed ID: 9677694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of fluoxetine and paroxetine in behavioral sensitization induced by ethanol in mice.
    Goeldner FO; Pigatto G; Ribeiro AF; Machado HB; Boerngen-Lacerda R
    Pharmacol Biochem Behav; 2005 Oct; 82(2):388-96. PubMed ID: 16219342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal delivery of paroxetine nanoemulsion via the olfactory region for the management of depression: formulation, behavioural and biochemical estimation.
    Pandey YR; Kumar S; Gupta BK; Ali J; Baboota S
    Nanotechnology; 2016 Jan; 27(2):025102. PubMed ID: 26629830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paxil study under fire.
    Wadman M
    Nature; 2011 Jul; 475(7355):153. PubMed ID: 21753826
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of antenatal exposure to paroxetine (paxil) on growth and physical maturation of mice offspring.
    Rayburn WF; Gonzalez CL; Christensen HD; Kupiec TC; Jacobsen JA; Stewart JD
    J Matern Fetal Med; 2000; 9(2):136-41. PubMed ID: 10902830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of the sigma1 receptor in the antidepressant-like effects of fluvoxamine in the forced swimming test in comparison with the effects elicited by paroxetine.
    Sugimoto Y; Tagawa N; Kobayashi Y; Mitsui-Saito K; Hotta Y; Yamada J
    Eur J Pharmacol; 2012 Dec; 696(1-3):96-100. PubMed ID: 23041149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.
    Wade A; Crawford GM; Angus M; Wilson R; Hamilton L
    Int Clin Psychopharmacol; 2003 May; 18(3):133-41. PubMed ID: 12702891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated paroxetine treatment reverses anhedonia induced in rats by chronic mild stress or dexamethasone.
    Casarotto PC; Andreatini R
    Eur Neuropsychopharmacol; 2007 Nov; 17(11):735-42. PubMed ID: 17462866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First experiences in combination therapy using olanzapine with SSRIs (citalopram, paroxetine) in delusional depression.
    König F; von Hippel C; Petersdorff T; Neuhöffer-Weiss M; Wolfersdorf M; Kaschka WP
    Neuropsychobiology; 2001; 43(3):170-4. PubMed ID: 11287796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The anxyolytic effect of mild hypobaric hypoxia in a model of post-traumatic stress disorder in rats].
    Rybnikova EA; Mironova VI; Tiul'kova EI; Samoĭlov MO
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2008; 58(4):486-92. PubMed ID: 18825947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic prenatal exposure to paroxetine (Paxil) and cognitive development of mice offspring.
    Christensen HD; Rayburn WF; Gonzalez CL
    Neurotoxicol Teratol; 2000; 22(5):733-9. PubMed ID: 11106866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alopecia areata with comorbid depression: early resolution with combined paroxetine-triamcinolone treatment.
    Ricciardi A; Ruberto A; García-Hernández MJ; Kotzalidis GD; Trevisi M; Persechino S; Tatarelli R; Ruiz-Doblado S
    J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):1000-1. PubMed ID: 16922952
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment-related improvement in neuropsychological functioning in suicidal depressed patients: paroxetine vs. bupropion.
    Gorlyn M; Keilp J; Burke A; Oquendo M; Mann JJ; Grunebaum M
    Psychiatry Res; 2015 Feb; 225(3):407-12. PubMed ID: 25555415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of olanzapine augmentation of paroxetine therapy in patients with severe body dysmorphic disorder.
    Nakaaki S; Murata Y; Furukawa TA
    Psychiatry Clin Neurosci; 2008 Jun; 62(3):370. PubMed ID: 18588607
    [No Abstract]   [Full Text] [Related]  

  • 19. Withdrawal reactions of a premature neonate after maternal use of paroxetine.
    Nijhuis IJ; Kok-Van Rooij GW; Bosschaart AN
    Arch Dis Child Fetal Neonatal Ed; 2001 Jan; 84(1):F77. PubMed ID: 11199858
    [No Abstract]   [Full Text] [Related]  

  • 20. High-dose paroxetine treatment for an adolescent with obsessive-compulsive disorder comorbid with Asperger's disorder.
    Sasayama D; Sugiyama N; Imai J; Hayashida A; Harada Y; Amano N
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):251. PubMed ID: 19335398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.